Dashboard
Manage Tickers

CREGSmart Powerr Corp.

Nasdaq www.creg-cn.com


$ 0.89 $ 0.03 (3.63 %)    

Friday, 16-Aug-2024 12:45:33 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.12 $ 1.00 (0.21 %)
DIA $ 408.83 $ -0.40 (-0.1 %)
SPY $ 560.33 $ 0.40 (0.07 %)
TLT $ 98.96 $ 0.28 (0.28 %)
GLD $ 232.06 $ 0.40 (0.17 %)
$ 0.9194
$ 0.87 x 100
$ 0.92 x 200
-- - --
$ 0.80 - $ 2.00
4,532
na
8.06M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 04-11-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 06-21-2023 03-31-2023 10-Q
7 05-08-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 10-11-2022 06-30-2022 10-Q
10 10-11-2022 03-31-2022 10-Q
11 09-13-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 04-15-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 06-29-2020 03-31-2020 10-Q
19 05-14-2020 12-31-2019 10-K
20 11-15-2019 09-30-2019 10-Q
21 08-16-2019 06-30-2019 10-Q
22 05-20-2019 03-31-2019 10-Q
23 04-16-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-13-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-29-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-23-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION